Integral Diagnostics Ltd
ASX:IDX
Wall Street
Price Targets
IDX Price Targets Summary
Integral Diagnostics Ltd
According to Wall Street analysts, the average 1-year price target for IDX is 2.46 AUD with a low forecast of 1.87 AUD and a high forecast of 3.24 AUD.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Integral Diagnostics Ltd
For the last 8 years the compound annual growth rate for Integral Diagnostics Ltd's operating income is 6%. The projected CAGR for the next 3 years is 19%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IDX's stock price target?
Price Target
2.46
AUD
According to Wall Street analysts, the average 1-year price target for IDX is 2.46 AUD with a low forecast of 1.87 AUD and a high forecast of 3.24 AUD.
What is Integral Diagnostics Ltd's Revenue forecast?
Projected CAGR
7%
For the last 8 years the compound annual growth rate for Integral Diagnostics Ltd's revenue is 14%. The projected CAGR for the next 3 years is 7%.
What is Integral Diagnostics Ltd's Operating Income forecast?
Projected CAGR
19%
For the last 8 years the compound annual growth rate for Integral Diagnostics Ltd's operating income is 6%. The projected CAGR for the next 3 years is 19%.
What is Integral Diagnostics Ltd's Net Income forecast?
Projected CAGR
10%
For the last 8 years the compound annual growth rate for Integral Diagnostics Ltd's net income is 24%. The projected CAGR for the next 3 years is 10%.